Public annual accounts

Ceropegia financials

A multi-period view of the public annual-account figures reported for Ceropegia, with comparable measures and links to available source documents.

Company overview
Registry number

0840752250

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Dec 31, 2025

Financial evidence

2025 versus 2024

Operating line
€18,301

-5.7%

EBITDA
€17,902

-5.9%

Total assets
€109,005

+4.2%

Equity
€90,753

+4.9%

EBITDA margin +97.8% · Equity ratio +83.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€18,301€17,902€109,005€90,753-
202431 Dec 2024€19,414€19,026€104,658€86,494-
Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report